Viral Vector Manufacture
Viral Vectors for CGT
Technologies
About us

Seite wählen

Home / About us / Newsroom

Newsroom

If you like to receive our Newsletter directly by email, please subscribe here.

Newsletter
Press Releases
News of Interest
Media Coverage
Investor News

Management
Company
References and Publications
Newsroom
Careers
Contact us

contact us

Contact us

Whether you seek help customizing a vector for academic use or support for your industrial R&D, we will assist you from square one to discuss and plan your project in detail.

News

SIRION Opens New Research And Manufacturing Center for Viral Vector Engineering In Munich Learn More

SIRION Biotech Achieves ISO 9001:2015 Certification Learn More

Meet us at

Webinar: Developing Lentiviral Vectors for ex vivo and in vivo Gene Therapy

On Demand Optimizing vector design for improved quality and safety
› more

Webinar: Engineering AAV Lead Vectors for Gene Therapy

On Demand Optimizing vector design at R&D and preclinical stages for improved safety and efficiency
› more

ASGCT 2022

16-19 May Washington DC
› more

BIO Europe 2021

25-28 October Virtual Congress
› more

Follow us

Google
Facebook
Twitter
Linkedin

Newsletter

SIRION Biotech’s Viral Vector Technologies for every application, from gene therapy and vaccination development to customization of cell modeling tools.

Viral Vector Manufacture
Viral Vectors for CGT
Technologies
About us

© Sirion-Biotech GmbH 2022

Terms & Conditions
Legal / Impressum
Privacy Statement